A new drug called retatrutide has shown some amazing results in a recent trial. People who took it lost a lot of weight and felt less pain in their knees. This drug is made by a company called Eli Lilly, which already has other popular drugs for weight loss and diabetes. The trial lasted about a ye
The hunt for new cancer treatments is tough and pricey. But what if we could use old drugs in new ways? That's where machine learning (ML) comes in. It's a type of smart tech that can spot patterns and make predictions. Researchers are using it to find new uses for existing drugs. This could save ti
Huntsville, Alabama, is about to get a major boost. Eli Lilly, a big name in the pharmaceutical world, is putting $6 billion into a new facility there. This isn't just any old factory; it's a high-tech hub for making advanced medicines. The focus will be on small molecule synthetic and peptide medic
Gannet BioChem, a top player in the specialty chemical industry, has just hit a major milestone. They've got the green light from the Science Based Targets initiative (SBTi) for their plans to cut down on greenhouse gas emissions. This isn't just any old goal-setting; it's a big deal in the world of
In the world of science, there are many unsung heroes. One such hero is a person who worked in the pharmaceutical industry. Their job was to protect science from harmful policies. But their life changed when they faced a serious health issue. It all began with a bad backache. They ignored it at fir
Semaglutide, the star ingredient in weight-loss drugs Ozempic and Wegovy, just took a big hit. Two major trials showed it doesn't help people with early Alzheimer's or mild memory issues. Thousands of people aged 55 to 85 took part, but the results were clear: no improvement in memory or daily funct
Eli Lilly has decided to lower the prices of its weight loss drug, Zepbound, for people who pay out of pocket. This change is part of a bigger effort to make the medication more accessible to those who need it. The company announced that starting this week, the initial dose of Zepbound vials will co
Eli Lilly, a big name in the drug world, just hit a huge milestone. It became the first healthcare company to reach a market value of $1 trillion. That's a lot of money! The company's stock hit this mark briefly during trading but then settled a bit lower, with each share going for around $1, 048.
Cindy Eckert, a woman who loves pink, is the CEO of Sprout Pharmaceuticals. Her company makes a drug called Addyi, which helps women with low sex drive. This condition is known as hypoactive sexual desire disorder (H. S. D. D. ). Addyi is often called the "little pink pill" and is different from Via
The stock market had a rollercoaster week, with the S&P 500 taking a hit but bouncing back. Investors are being cautious, especially with Big Tech's big spending and high valuations. Experts suggest sticking with companies that are actually making money, like Nvidia, Microsoft, and Alphabet, instead
